Literature DB >> 5897831

Two principles in endocrine therapy of cancers: hormone deprival and hormone interference.

C Huggins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5897831

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  21 in total

1.  Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone.

Authors:  J S Sack; K F Kish; C Wang; R M Attar; S E Kiefer; Y An; G Y Wu; J E Scheffler; M E Salvati; S R Krystek; R Weinmann; H M Einspahr
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 2.  Intracrinology-revisited and prostate cancer.

Authors:  Trevor M Penning; Andrea J Detlefsen
Journal:  J Steroid Biochem Mol Biol       Date:  2019-10-12       Impact factor: 4.292

Review 3.  Role of androgen receptor splice variants, their clinical relevance and treatment options.

Authors:  S Wach; H Taubert; M Cronauer
Journal:  World J Urol       Date:  2019-01-19       Impact factor: 4.226

Review 4.  Dehydroepiandrosterone (DHEA)-SO4 Depot and Castration-Resistant Prostate Cancer.

Authors:  Trevor M Penning
Journal:  Vitam Horm       Date:  2018-02-24       Impact factor: 3.421

Review 5.  The convergence of hormone regulation and cell cycle in prostate physiology and prostate tumorigenesis.

Authors:  Joanne N Davis; Mark L Day
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

6.  Raloxifene and/or estradiol decrease anxiety-like and depressive-like behavior, whereas only estradiol increases carcinogen-induced tumorigenesis and uterine proliferation among ovariectomized rats.

Authors:  Alicia A Walf; Cheryl Anne Frye
Journal:  Behav Pharmacol       Date:  2010-05       Impact factor: 2.293

7.  Bipolar Androgen Therapy: A Paradoxical Approach for the Treatment of Castration-resistant Prostate Cancer.

Authors:  Michael T Schweizer; Emmanuel S Antonarakis; Samuel R Denmeade
Journal:  Eur Urol       Date:  2017-03-29       Impact factor: 20.096

8.  Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy.

Authors:  R C Guzman; J Yang; L Rajkumar; G Thordarson; X Chen; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

9.  A 3-(4-nitronaphthen-1-yl) amino-benzoate analog as a bifunctional AKR1C3 inhibitor and AR antagonist: Head to head comparison with other advanced AKR1C3 targeted therapeutics.

Authors:  Phumvadee Wangtrakuldee; Adegoke O Adeniji; Tianzhu Zang; Ling Duan; Buddha Khatri; Barry M Twenter; Michelle A Estrada; Tyler F Higgins; Jeffrey D Winkler; Trevor M Penning
Journal:  J Steroid Biochem Mol Biol       Date:  2019-01-11       Impact factor: 4.292

10.  Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis.

Authors:  Ronald A Lubet; Eva Szabo; Kenneth K Iwata; Stanley C Gill; Chris Tucker; Ann Bode; Vernon E Steele; M Margaret Juliana; Holly L Nicastro; Clinton J Grubbs
Journal:  Cancer Prev Res (Phila)       Date:  2013-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.